Toggle navigation
PathBank
Browse
Pathways
Table of Primary Pathways
Compounds
Proteins
Search
Advanced Text Search
ChemQuery Structure Search
Molecular Weight Search
Sequence Search
Analyze
Over-Representation Analysis
Path-MAP Analysis
Pathway Enrichment Analysis
About
About PathBank
Statistics
Style Guide
Other Databases
Pathway Legend
Pathway Category Definitions
PathWhiz
Downloads
Contact Us
Quantitative metabolomics services for biomarker discovery and validation.
Specializing in ready to use metabolomics kits.
Your source for quantitative metabolomics technologies and bioinformatics.
Loading Pathway...
Error: Pathway image not found.
D(2) dopamine
receptor
D(1A) dopamine
receptor
D(1B) dopamine
receptor
Voltage-
dependent
P/Q-type
calcium channel
subunit
alpha-1A
Voltage-
dependent
L-type calcium
channel subunit
beta-1
Voltage-
dependent
calcium channel
subunit
alpha-2/delta-2
Sodium-
dependent
dopamine
transporter
Synaptic
vesicular amine
transporter
Aromatic-L-
amino-acid
decarboxylase
Tyrosine
3-monooxygenase
Dopamine
Ca
+
Acepromazine
Acepromazine
Ca
+
Dopamine
Dopamine
Acepromazine
Acepromazine
Acepromazine
L-Dopa
CO
2
L-Tyrosine
Tetrahydrobiopterin
O
2
Dihydrobiopterin
H
2
O
Na
+
Na
+
Pyridoxal
5'-phosphate
Gi signaling
cascade
Gi Signaling
Cascade
Fe2+
Cytosol
Postsynaptic Neuron
Presynaptic Neuron
Cytosol
Synaptic Vesicle
Synapse
Acepromazine is a D1 and D2
receptor antagonist. D2
receptors in the mesolimbic
pathway are responsible for
producing the positive
symptoms in schizophrenia
↓ Positive, negative and
cognitive symptoms of
schizophrenia and psychosis
Excess dopamine in the brain
triggers positive symptoms
of schizophrenia
Brain
Mesolimbic pathway
Blood vessel - blood brain
barrier
Passive Diffusion
Passive Diffusion
Acepromazine blocks dopamine
receptors and depresses the
reticular-activating system,
resulting in sedation
Acepromazine is taken orally
and absorbed from the
gastrointestinal tract
DRD2
DRD1
DRD5
CACNA1A
CACNB1
CACNA2D2
SLC6A3
SLC18A2
DDC
TH
Dopamine
Calcium
Acepromazine
Acepromazine
Calcium
Dopamine
Dopamine
Acepromazine
Acepromazine
Acepromazine
L-Dopa
Carbon dioxide
L-Tyrosine
Tetrahydrobiopterin
Oxygen
Dihydrobiopterin
Water
Sodium
Sodium
Gi signaling
cascade
Gi Signaling
Cascade
DRD2
DRD1
DRD5
CACNA1A
CACNB1
CACNA2D2
SLC6A3
SLC18A2
DDC
TH
LDP
Ca
+
Acetazi
Acetazi
Ca
+
LDP
LDP
Acetazi
Acetazi
Acetazi
L-Dopa
CO
2
Tyr
BH4
O
2
BH3
H
2
O
Na
+
Na
+
Pyr-5'P
Gi si c
Gi Si C
Fe2+
Cytosol
Postsynaptic Neuron
Presynaptic Neuron
Cytosol
Synaptic Vesicle
Synapse
Acepromazine is a D1 and D2
receptor antagonist. D2
receptors in the mesolimbic
pathway are responsible for
producing the positive
symptoms in schizophrenia
↓ Positive, negative and
cognitive symptoms of
schizophrenia and psychosis
Excess dopamine in the brain
triggers positive symptoms
of schizophrenia
Brain
Mesolimbic pathway
Blood vessel - blood brain
barrier
Passive Diffusion
Passive Diffusion
Acepromazine blocks dopamine
receptors and depresses the
reticular-activating system,
resulting in sedation
Acepromazine is taken orally
and absorbed from the
gastrointestinal tract